Literature DB >> 12215192

Adverse dermatologic effects of cardiovascular drug therapy: part II.

William H Frishman1, Brian D Brosnan, Marc Grossman, Debasish Dasgupta, Diana K Sun.   

Abstract

Cardiovascular disease is common, affecting an increasing number of persons as the population ages. To combat this growing health problem, physicians use a multitude of medications in the treatment of their patients. Although pharmacologic therapy greatly enhances quality of life for a majority of patients, there is always the potential for an unfavorable reaction. For example, cardiovascular drugs can induce a vast array of adverse dermatologic responses. This article reviews the various cutaneous reaction patterns that can occur as a result of treatment with class III, IV, and other antiarrhythmic agents, ACE inhibitors, Angiotensin II receptor blockers, and diuretics.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12215192     DOI: 10.1097/00045415-200209000-00005

Source DB:  PubMed          Journal:  Cardiol Rev        ISSN: 1061-5377            Impact factor:   2.644


  4 in total

1.  Case studies in anticoagulation management.

Authors:  Wendy A Leong
Journal:  J Thromb Thrombolysis       Date:  2007-10-01       Impact factor: 2.300

2.  Antihypertensive drugs and lip cancer in non-Hispanic whites.

Authors:  Gary D Friedman; Maryam M Asgari; E Margaret Warton; James Chan; Laurel A Habel
Journal:  Arch Intern Med       Date:  2012-09-10

3.  Hydrochlorothiazide use, sun exposure, and risk of keratinocyte cancer.

Authors:  Jeffrey J VanWormer; Eseoghene B Abokede; Richard L Berg
Journal:  BMC Public Health       Date:  2022-07-02       Impact factor: 4.135

4.  Use of photosensitising diuretics and risk of skin cancer: a population-based case-control study.

Authors:  A Ø Jensen; H F Thomsen; M C Engebjerg; A B Olesen; H T Sørensen; M R Karagas
Journal:  Br J Cancer       Date:  2008-09-23       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.